Practiceby Lab 10 Get started ›
Crossfire

Should a healthy adult take an NAD booster (NMN or NR) to slow aging?

What the experts say

Peter AttiaMD · longevity physician, founder of Early Medical

No. The case is still theoretical, and the human results claiming benefit do not hold up.

What it rests onConcedes NAD declines with age and that NMN raises circulating NAD, but argues intracellular NAD is the variable that matters, that human studies conflict, and that the trial showing benefits used an unvalidated biological-age calculator and a six-minute walk test that cannot detect fitness differences in healthy adults.

Source: peterattiamd.com ↗
David A. SinclairPhD · Professor of Genetics, Harvard Medical School

NAD precursors are a central part of his longevity protocol and he reviews them as promising.

What it rests onDedicates a full Lifespan episode to NAD boosters (NR, NMN, IV drips), with a section on his own protocol for longevity molecules. The same show notes carry a published dosage correction, which is a signal about the channel rather than about the compound.

Source: lifespanpodcast.com ↗

Overview

Attia is arguing about healthy adults, and the trial he reviews enrolled healthy people aged 40 to 65. Sinclair's case leans on mechanism, animal work and biomarker studies rather than on outcome trials in healthy adults.

Where they agree

Both accept that NAD declines with age, that NAD matters for DNA repair, and that oral NMN can raise circulating NAD levels.

What would settle it

A randomized human trial with hard outcomes, or a validated measure of intracellular NAD showing that supplementation raises it.

Practice does not pick a winner here

You do, and your call is dated, kept, and yours to change. Follow the people you already trust and what they publish turns into a short daily practice.

Get started

Free to sign up and use. We do not ask for a card.